These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1008612)

  • 1. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
    Ackermann-Schopf CM
    Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antibodies in malignant melanoma patients.
    Betterle C; Peserico A; Bersani G; Ninfo V; Del Prete GF; Stefani R; Nitti D
    Dermatologica; 1979; 159(1):24-9. PubMed ID: 383530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal cytoplasmic antigens: II. Concurrent presence of antigens of different specificities in normal human skin.
    Bystryn JC; Nash M; Robins P
    J Invest Dermatol; 1978 Aug; 71(2):110-3. PubMed ID: 79622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic alterations in tumors of epidermal origin.
    Tosca A; Varelzidis A; Nicolis G; Hadzis J; Stratigos J; Capetanakis J
    Cancer; 1980 May; 45(9):2284-90. PubMed ID: 7379027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to detect circulating IgG or IgM antibodies to basal cell carcinoma by immunofluorescence.
    Blewitt RW; Aparicio SR; Burrow HM; Rowell NR; Rowell RM
    Acta Derm Venereol; 1978; 58(1):82-3. PubMed ID: 75642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma.
    Abel EA; Bystryn JC
    J Invest Dermatol; 1976 Jan; 66(1):44-8. PubMed ID: 1107434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in cancer patients.
    Nelson DS
    Pathology; 1977 Apr; 9(2):155-60. PubMed ID: 301627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to human epidermal cytoplasmic antigens: incidence, patterns, and titers.
    Paluch EP; Bloch KJ
    J Invest Dermatol; 1982 Aug; 79(2):115-8. PubMed ID: 7047651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the antigen recognized by mAb GB36 in normal skin and in skin tumours.
    Hofman P; Lacour JP; Emiliozzi C; Staquet MJ; Hsi BL; Rossi B; Ortonne JP
    Br J Dermatol; 1995 Dec; 133(6):874-83. PubMed ID: 8547038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal cytoplasmic antibodies. (Incidence and clinical significance).
    Betterle C; Peserico A; Bersani G; Rigon F; Del Prete G
    Ric Clin Lab; 1977; 7(3):242-51. PubMed ID: 343221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental production of antibodies against stratum corneum keratin polypeptides.
    Viac J; Staquet MJ; Thivolet J; Goujon C
    Arch Dermatol Res; 1980; 267(2):179-88. PubMed ID: 6157367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody labelling the keratinocyte membrane: a marker of epidermal differentiation.
    Viac J; Haftek M; Staquet MJ; Reano A; Brochier J; Thivolet J
    Acta Derm Venereol; 1985; 65(1):1-8. PubMed ID: 2578699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cross-reacting antigen common to stratified squamous epithelium and Streptococcus group A in tumors of epidermal origin].
    Silagadze DG; Beletskaia LV; Berenbein VA; Kolesnikova VIu
    Vopr Onkol; 1981; 27(6):27-32. PubMed ID: 7023039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen in skin and related tumours as determined by immunohistological techniques.
    Scurry J; de Boer WG
    Pathology; 1983 Oct; 15(4):379-84. PubMed ID: 6371679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial distribution of a myelomonocytic antigen LI in relation to cutaneous malignancies and melanocytic naevi.
    Gabrielsen TO; Brandtzaeg P; Hoel PS; Dale I
    Br J Dermatol; 1988 Jan; 118(1):59-67. PubMed ID: 3277660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Langerhans cells and expression of class II antigens on keratinocytes in malignant and benign epithelial tumors of the skin: an immunohistopathologic study with monoclonal antibodies.
    Chen HD; Zhao YM; Sun G; Yang CY
    J Am Acad Dermatol; 1989 Jun; 20(6):1007-14. PubMed ID: 2474010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma and nonmelanoma skin cancers and the immune system.
    Domingo DS; Baron ED
    Adv Exp Med Biol; 2008; 624():187-202. PubMed ID: 18348457
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in antigenic properties of normal epidermis adjacent to basal cell carcinomas.
    Wolf D; Bystryn JC
    J Invest Dermatol; 1981 Jun; 76(6):442-4. PubMed ID: 7240790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis.
    Ban L; Labbouz S; Grindlay D; Batchelor JM; Ratib S
    Br J Dermatol; 2018 Oct; 179(4):971-972. PubMed ID: 29704869
    [No Abstract]   [Full Text] [Related]  

  • 20. A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors.
    Stanley JR; Beckwith JB; Fuller RP; Katz SI
    Cancer; 1982 Oct; 50(8):1486-90. PubMed ID: 6288214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.